This is to inform you that the Company ahs acquired 2,09,100 equity shares of Ishwari Healthcare Private Limited (51.00% of paid up equity share capital) at a revised consideration of Rs.1,50,00,000/- ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries Ltd has completed the acquisition of 2,09,100 equity shares (51% of paid-up capital) of Ishwari Healthcare Private Limited, making it a subsidiary effective from 1st April 2025. The shares were bought from Mr. Shatrughan Nenwani at a per-share price of Rs. 71.73, taking the total revised consideration to Rs. 1.50 crore. This is significantly lower than the originally approved consideration of Rs. 2.60 crore announced in October 2024, after multiple rounds of negotiation. The acquisition was carried out under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
The deal was closed at a 42% lower valuation than initially proposed, which is favourable for Sudarshan Pharma's shareholders. Ishwari Healthcare becoming a subsidiary means the company will now consolidate its financials, which could add to top-line revenue but also introduces integration risks.